use of pimobendan to reduce heart size and / or delay the onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

摘要

The invention relates to pimobendan for use in a method of reducing heart size and / or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure. due to mitral valve disease (mvd) and / or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (mvd), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse and more preferably a dog.